Document Detail


Clinical Correlates of CENP-A and CENP-B Antibodies in a Large Cohort of Patients with Systemic Sclerosis.
MedLine Citation:
PMID:  22467948     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: To study the clinical phenotypes of centromeric proteins (CENP)-A- and CENP-B-positive patients with systemic sclerosis (SSc) and to compare them to anticentromere antibody (ACA)-positive and negative SSc patients.
METHODS: Sera samples were collected from 802 patients with SSc enrolled in a multicenter cohort study. Antibodies to CENP-A and B were detected by ELISA, and ACA by indirect immunofluorescence. Associations with clinical and other serological manifestations of SSc were investigated.
RESULTS: CENP-A antibodies were detected in 276 (34%), CENP-B in 286 (36%), and ACA in 279 (35%) patients. Patients having ACA, CENP-A, and/or CENP-B resembled each other and differed from the remainder of the cohort in the following respects: older chronologically and at disease onset; more commonly women; more likely to have limited disease and lower skin scores; less likely to have finger ulcers, digital tuft resorption, or finger contractures; more likely to have pulmonary hypertension; less likely to have interstitial lung disease, scleroderma renal crisis, inflammatory arthritis, and inflammatory myositis; and having lower overall disease severity. CENP-A and/or B status was predictive of the extent of skin involvement over time. Patients with limited disease who were CENP-A-negative at baseline were more likely to progress to diffuse disease compared to CENP-A-positive patients (OR 2.55, 95% CI 1.37, 4.85, p = 0.004).
CONCLUSION: Clinical immunology laboratories are increasingly using high-throughput ELISA tests for CENP antibodies, with or without ACA detected by indirect immunofluorescence. The phenotype of CENP-A and/or B-positive patients is generally similar to that associated with ACA.
Authors:
Marie Hudson; Michael Mahler; Janet Pope; Daniel You; Solene Tatibouet; Russell Steele; Murray Baron; ; Marvin Fritzler
Related Documents :
21468168 - Value of procalcitonin, c-reactive protein, and neopterin in exacerbations of chronic o...
21404958 - Hyperosmolar hyperglycemic syndrome with rhabdomyolysis.
12087558 - Quality of prereferral care in patients with chronic renal insufficiency.
1794018 - Electrolyte disorders in the elderly.
3591288 - Screening for cystic fibrosis. a comparative study.
8379198 - Diagnostic approach to thyroid carcinoma in graves' disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of rheumatology     Volume:  39     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  787-94     Citation Subset:  IM    
Affiliation:
Jewish General Hospital, Room A-725, 3755 Cote Ste Catherine Road, Montreal, Quebec H3T 1E2, Canada. marie.hudson@mcgill.ca.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Investigator
Investigator/Affiliation:
J Markland / ; D Robinson / ; N Jones / ; N Khalidi / ; P Docherty / ; E Kaminska / ; A Masetto / ; E Sutton / ; J-P Mathieu / ; S Ligier / ; T Grodzicky / ; C Thorne / ; S Leclercq /

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of riboflavin-ultraviolet A-induced collagen cross-linking on intraocular pressure measur...
Next Document:  Antioxidant Activities and Oxidative Stabilities of Some Unconventional Oilseeds.